Universal Infant Hepatitis B Vaccination programme

Cost effectiveness analysis of a universal infant hepatitis B vaccination programme in Ireland

 

In October 2006, the National Centre for Pharmacoeconomics conducted an economic evaluation of the cost-effectiveness of a universal hepatitis B vaccination programme, for the Health Protection Surveillance Centre/National Immunisation Advisory Committee. A summary of the main findings are available in the attached document.

 

Universal Infant Hepatitis B Vaccine Programme summary